Indore to get largest Ayush hospital in division in May
Indore: Indore is set to get the division's largest AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homeopathy) hospital next month. The 50-bed AYUSH hospital, constructed in Mangliya under the Sanwer Assembly constituency of Indore, is nearing completion.
To ensure the smooth operation of the hospital, cabinet minister Tulsiram Silawat recently met with AYUSH and higher education minister Inder Singh Parmar. He requested the allocation of approximately Rs 10.26 crore for various essential works, including the construction of ramps, retaining walls, procurement of equipment, development of a herbal garden and fire-fighting system, provision of furniture and a fire tank, and other necessary infrastructure.
"This hospital will be the largest and most well-equipped AYUSH hospital in the Indore division under the AYUSH department," Silawat said, adding that the 50-bed govt AYUSH hospital was built at a cost of approximately Rs 6 crore. "While the civil work is complete, the installation of medical facilities and equipment is the only remaining task, which is expected to be finished soon," he said, adding that a provision was made for 10 air conditioners and an ambulance for the hospital.
"The hospital will offer all modern treatment facilities, including sonography, pathology, CT scan, and X-ray diagnostic services," he said, adding that the hospital will also facilitate childbirth for pregnant women and provide treatments through Panchakarma and Yoga.
In the hospital premises, a new garden has been developed while the beautification of the adjacent drain is underway.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
an hour ago
- Economic Times
Stock Radar: P&G Health stock gave a breakout from falling trendline on weekly charts; check target & stop loss
Procter & Gamble Health Ltd, part of the pharma industry, gave a breakout from a falling trendline resistance to hit fresh 52-week high on the weekly charts which has opened room for the stock to head traders can look to buy stock for a target of Rs 6,700 in the next 2-3 months, suggest pharma stock consolidated in a narrow range post November 2024. It found support above 5,000 levels which has also acted as a
Time of India
an hour ago
- Time of India
On humanitarian grounds, HC grants interim bail to woman with cancer
New Delhi: Taking a humanitarian view, Delhi High Court has granted interim bail to a woman suffering from cancer, noting the seriousness of her medical condition. The woman, identified as Jyoti, is an accused in a drug recovery case registered by the Delhi Police Crime Branch under the stringent Narcotic Drugs and Psychotropic Substances (NDPS) Act. She had approached the HC seeking interim relief on medical grounds. In its order dated June 4, the court noted that Jyoti is suffering from a terminal illness and requires urgent medical attention. "Keeping in view the extreme and terminal medical condition of the applicant and the humanitarian medical crisis which has arisen, the application seeking interim bail needs to be allowed," the court observed. The bench granted her interim bail until June 15, 2025, directing that she be released upon furnishing a personal bond of Rs 1,00,000 with one surety of the same amount, to the satisfaction of the jail superintendent or the Trial Court. The court also issued notice to the state and asked the Investigating Officer to verify Jyoti's medical documents and submit a status report by June 13, the next date of hearing. Jyoti was earlier granted interim bail by the trial court from May 19 to June 5, 2025, citing her medical condition. However, when she applied for an extension, the trial court declined, noting that she had also filed a regular bail application which was still pending before the HC. In her fresh plea before the HC, Jyoti submitted medical documents confirming that she is suffering from Chronic Lymphocytic Leukaemia, a rare form of cancer that requires ongoing monitoring and treatment. Her counsel argued that denying her continued interim bail would severely compromise her right to health and access to essential medical care. The HC's intervention came after the trial court refused further extension, prompting Jyoti to seek urgent relief amid what her lawyers described as a medical emergency.
Time of India
3 hours ago
- Time of India
Tenecteplase injection saves 2,650 lives in Andhra Pradesh under STEMI
1 2 3 Visakhapatnam: Under the STEMI (ST-elevated myocardial infarction) programme, which aims to enable treatment for heart attacks during the critical golden hour, Tenecteplase injections costing approximately Rs 45,000 are being provided free of charge to eligible patients in Andhra Pradesh. This initiative by the state health department has so far saved around 2,650 lives since the programme's inception about 10 months ago. According to experts, thrombolytic therapy using Tenecteplase is crucial during the golden hour for patients experiencing acute myocardial infarction. The golden hour represents the vital window during which immediate medical intervention can significantly improve patient outcomes. This clot-dissolving medication works by breaking down blood clots that obstruct blood flow to the heart. State health minister Satya Kumar Yadav said that the costly injection is being provided free of charge to patients, which has helped save 2,650 lives. "I appreciate all the stakeholders involved in this STEMI mission," Yadav added. When administered properly, Tenecteplase helps restore blood flow through blocked arteries. The earlier the treatment, the better the chance of preserving heart muscle and reducing mortality. Similarly, in cases of ischaemic stroke, prompt administration of Tenecteplase within the approved time window is essential to avoid permanent brain damage. Dr K Rambabu, director of the Visakha Institute of Medical Sciences (VIMS), explained that approximately 40 mg is administered to patients with myocardial infarction (MI), while 20 mg is used for those suffering from ischaemic stroke. "After stabilising myocardial infarction patients with this thrombolytic therapy at VIMS, they are referred to hospitals equipped with cath labs. Stroke patients, however, are treated at VIMS itself. Thanks to the govt, the free injection is a blessing for poor patients. It facilitates recovery during the critical golden hour. VIMS has requested the establishment of a cath lab, which would not only aid in treating MI patients but also allow advanced procedures such as embolisation," Dr Rambabu said. Ch Jagannadha Rao, a 70-year-old patient, shared his experience after being admitted to VIMS for right-sided weakness in both upper and lower limbs (stroke). "I noticed my mouth was deviating to the left, and I was slurring my speech. The doctors told me a CT scan showed no haemorrhage. They administered a Tenecteplase injection, and within an hour, I noticed improvement in my right limbs and speech. They continued my treatment with other medications. After five days, I could walk unaided and speak normally. I was discharged after nine days, fully recovered," Rao said. The STEMI programme operates under a hub-and-spoke model. Major hospitals function as hubs, while selected community health centres, area hospitals, and district hospitals are connected to these hubs and serve as 'spokes'. If a person experiences chest pain, they can visit the nearest smaller hospital (a spoke), where doctors perform an ECG. Senior specialists at the hub then review the data and determine if the Tenecteplase injection is required. If so, doctors at the spoke administer it immediately, and the patient is subsequently transferred to the hub for further treatment.
